[Therapeutics in 1978].
D000568:Amenorrhea / Q000188:drug therapy; D000924:Anticholesteremic Agents / Q000009:adverse effects; D001187:Artificial Organs; D001660:Biliary Tract Diseases / Q000378:metabolism; D001971:Bromocriptine / Q000627:therapeutic use; D002769:Cholelithiasis / Q000139:chemically induced; D002994:Clofibrate / Q000009:adverse effects; D004358:Drug Therapy; D064420:Drug-Related Side Effects and Adverse Reactions; D004967:Estrogens / Q000009:adverse effects; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005687:Galactorrhea / Q000188:drug therapy; D005767:Gastrointestinal Diseases / Q000378:metabolism; D006801:Humans; D008107:Liver Diseases / Q000378:metabolism; D010179:Pancreas; D016035:Pancreas Transplantation; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D011247:Pregnancy; D011388:Prolactin / Q000097:blood; D013959:Thyroid Diseases / Q000378:metabolism; D014594:Uterine Neoplasms / Q000139:chemically induced
D000924:Anticholesteremic Agents; D004967:Estrogens; D005343:Fibrinolytic Agents; D004364:Pharmaceutical Preparations; D001971:Bromocriptine; D011388:Prolactin; D002994:Clofibrate
La thérapeutique en 1978.